Ca. Binkert et al., Can MR measurement of renal artery flow and renal volume predict the outcome of percutaneous transluminal renal angioplasty?, CARDIO IN R, 24(4), 2001, pp. 233-239
Purpose: Predicting therapeutic benefit from percutaneous transluminal rena
l angioplasty (PTRA) in patients with renal artery stenosis (RAS) remains d
ifficult. This study investigates whether magnetic resonance (MR)-based ren
al artery flow measurements relative to renal parenchymal volume can predic
t clinical outcome following PTRA.
Methods: The data on 23 patients (13 men, 10 women; age range 47-82 years,
mean age 64 years) were analyzed. The indication for treatment was hyperten
sion (n = 18) or renal insufficiency (n = 5). Thirty-four cases of RAS were
identified: bilateral disease was manifest in 11 and unilateral disease in
12 patients. The MR imaging protocol included a breath-hold, cardiac-gated
cine phase-contrast sequence for renal flow measurement and a fast multipl
anar spoiled gradient-echo sequence for renal volume measurement. MR measur
ements were performed on the day prior to and the day following PTRA. Clini
cal success was defined as (a) a reduction in diastolic blood pressure > 15
% or (b) a reduction in serum creatinine > 20%. Kidneys were categorized as
normal volume or low volume. A renal flow index (RFI) was calculated by di
viding the renal flow (ml/min) by the renal volume (cm(3)).
Results: Clinical success was observed in 11 patients. Twelve patients did
not benefit from angioplasty. Normal kidney volume was seen in 10 of 11 res
ponders and in 8 of 12 nonresponders, resulting in a sensitivity of 91%, sp
ecificity of 33%, a positive predictive value (PPV) of 56% and a negative p
redictive value (NPV) of 80%. A RFI below a threshold of 1.5 ml/min/cm(3) p
redicted successful outcome with 100% sensitivity, 33% specificity, 58% PPV
, and 100% NPV. The combination of normal renal volume and a RFI below 1.5
ml/min/cm(3) identified PTRA responders with a sensitivity of 91%, a specif
icity of 67%, a PPV of 71%, and a NPV of 89%. PTRA resulted in a greater in
crease in renal flow in responders compared with nonresponders (p < 0.001).
Conclusion: A combination of cine phase-contrast MR renal flow and parenchy
mal volume measurements enables identification of patients benefiting from
PTRA with a high sensitivity and NPV, but only moderate specificity and PPV
.